期刊论文详细信息
| International Journal of Clinical and Experimental Pathology | |
| Ribonucleotide reductase M2 does not predict survival in patients with resectable pancreatic adenocarcinoma | |
| Hao Xie1 | |
| 关键词: Ribonucleotide reductase M2; pancreatic cancer; resectable; gemcitabine; | |
| DOI : | |
| 学科分类：生理学与病理学 | |
| 来源: e-Century Publishing Corporation | |
 PDF
|
|
【 摘 要 】
BackgroundRibonucleotide reductase M2 (RRM2) was associated with pancreatic tumor progression and resistance to gemcitabine. This study aimed to determine if RRM2 protein expression was prognostic in patients with resectable pancreatic adenocarcinoma and predictive of adjuvant gemcitabine benefit.
【 授权许可】
CC BY-NC
【 预 览 】
| Files | Size | Format | View |
|---|---|---|---|
| RO201901239273771ZK.pdf | 258KB |  download |
878987797
028-85220240
